File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: A clinic-based study of BRCA1/2 mutation epidemiology in Asians

TitleA clinic-based study of BRCA1/2 mutation epidemiology in Asians
Authors
Issue Date2006
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6806
Citation
29th Annual San Antonio Breast Symposium, San Antonio, TX, 14-17 December 2006. In Breast Cancer Research and Treatment, 2006, v. 100 n. 1 Supp, p. S273-S274 Abstract no.6053 How to Cite?
AbstractBackground: Previous research suggests significant differences in the epidemiology of breast cancers associated with BRCA1/2 mutations among Asians and Caucasians. The BRCAPRO and Myriad II models are widely used to predict BRCA1/2 mutation carriage, but their accuracy has not been studied in Asians. We are conducting a clinic-based study of BRCA1/2 mutation prevalence, epidemiology of associated cancers, and performance of the BRCAPRO and Myriad II models in Asians and Caucasians. Methods: Patient clinical data and BRCA1/2 mutation testing results were collected through chart and database review from cancer genetics services at North American medical centers with a high volume of Asian patients. BRCA1/2 mutation testing was performed through full sequencing and evaluation for common gene rearrangements, in most cases by Myriad Genetics Incorporated (Salt Lake City, UT). BRCAPRO and Myriad II model scores were calculated centrally using CancerGene software, version 4b (University of Texas Southwestern, Dallas, TX). Results: Data are presented from the British Columbia Cancer Agency, Stanford University, and University of California at San Francisco. 41 of 126 patients (32.5%) carried a deleterious mutation in BRCA1 or BRCA2; 24 (19.0%) had a variant of uncertain signifi cance in one of these genes. The mean predicted probability of BRCA1/2 mutation carriage using the BRCAPRO model was 13.5%, which is signifi cantly (p<0.00001) different from the observed 32.5% of women with BRCA1/2 mutations, and 14.1% using the Myriad II model. Conclusions: Approximately one-third of clinically tested Asian women carry a deleterious mutation in BRCA1 or BRCA2. The BRCAPRO and Myriad II models under-estimated probability of mutation carriage in Asians. Comparison to Caucasian controls and to Asian patients in Hong Kong is underway to evaluate differences in BRCA1/2 mutation prevalence, epidemiology of associated cancers, and model performance.
Persistent Identifierhttp://hdl.handle.net/10722/182260
ISSN
2015 Impact Factor: 4.085
2015 SCImago Journal Rankings: 2.424

 

DC FieldValueLanguage
dc.contributor.authorKurian, AW-
dc.contributor.authorChun, NM-
dc.contributor.authorMills, MA-
dc.contributor.authorCrawford, BA-
dc.contributor.authorLee, R-
dc.contributor.authorRidge, Y-
dc.contributor.authorPanabaker, K-
dc.contributor.authorBennett, R-
dc.contributor.authorGong, GD-
dc.contributor.authorKwong, A-
dc.contributor.authorWest, DW-
dc.contributor.authorFord, JM-
dc.date.accessioned2013-04-19T07:06:47Z-
dc.date.available2013-04-19T07:06:47Z-
dc.date.issued2006-
dc.identifier.citation29th Annual San Antonio Breast Symposium, San Antonio, TX, 14-17 December 2006. In Breast Cancer Research and Treatment, 2006, v. 100 n. 1 Supp, p. S273-S274 Abstract no.6053-
dc.identifier.issn0167-6806-
dc.identifier.urihttp://hdl.handle.net/10722/182260-
dc.description.abstractBackground: Previous research suggests significant differences in the epidemiology of breast cancers associated with BRCA1/2 mutations among Asians and Caucasians. The BRCAPRO and Myriad II models are widely used to predict BRCA1/2 mutation carriage, but their accuracy has not been studied in Asians. We are conducting a clinic-based study of BRCA1/2 mutation prevalence, epidemiology of associated cancers, and performance of the BRCAPRO and Myriad II models in Asians and Caucasians. Methods: Patient clinical data and BRCA1/2 mutation testing results were collected through chart and database review from cancer genetics services at North American medical centers with a high volume of Asian patients. BRCA1/2 mutation testing was performed through full sequencing and evaluation for common gene rearrangements, in most cases by Myriad Genetics Incorporated (Salt Lake City, UT). BRCAPRO and Myriad II model scores were calculated centrally using CancerGene software, version 4b (University of Texas Southwestern, Dallas, TX). Results: Data are presented from the British Columbia Cancer Agency, Stanford University, and University of California at San Francisco. 41 of 126 patients (32.5%) carried a deleterious mutation in BRCA1 or BRCA2; 24 (19.0%) had a variant of uncertain signifi cance in one of these genes. The mean predicted probability of BRCA1/2 mutation carriage using the BRCAPRO model was 13.5%, which is signifi cantly (p<0.00001) different from the observed 32.5% of women with BRCA1/2 mutations, and 14.1% using the Myriad II model. Conclusions: Approximately one-third of clinically tested Asian women carry a deleterious mutation in BRCA1 or BRCA2. The BRCAPRO and Myriad II models under-estimated probability of mutation carriage in Asians. Comparison to Caucasian controls and to Asian patients in Hong Kong is underway to evaluate differences in BRCA1/2 mutation prevalence, epidemiology of associated cancers, and model performance.-
dc.languageeng-
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6806-
dc.relation.ispartofBreast Cancer Research and Treatment-
dc.rightsThe original publication is available at www.springerlink.com-
dc.titleA clinic-based study of BRCA1/2 mutation epidemiology in Asiansen_US
dc.typeConference_Paperen_US
dc.identifier.emailKwong, A: avakwong@hkucc.hku.hk-
dc.description.natureabstract-
dc.identifier.volume100-
dc.identifier.issue1 Supp-
dc.identifier.spageS273-
dc.identifier.epageS274 Abstract no.6053-
dc.publisher.placeUnited States-
dc.description.other29th Annual San Antonio Breast Symposium, San Antonio, TX, 14-17 December 2006. In Breast Cancer Research and Treatment, 2006, v. 100 n. 1 Supp, p. S273-S274 Abstract no.6053-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats